Does Pemetrexed Work in Targetable, Nonsquamous Non-Small-Cell Lung Cancer? A Narrative Review

SIMPLE SUMMARY: The chemotherapy agent pemetrexed is currently considered in combination with other therapies for the treatment of advanced nonsquamous non-small-cell lung cancer (NSCLC) in patients negative for gene mutations/rearrangements. The aim of this review was to highlight data from clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Jin-Yuan, Inoue, Akira, Cheng, Rebecca, Varea, Rocio, Kim, Sang-We
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563381/
https://www.ncbi.nlm.nih.gov/pubmed/32957736
http://dx.doi.org/10.3390/cancers12092658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563381/
https://www.ncbi.nlm.nih.gov/pubmed/32957736
http://dx.doi.org/10.3390/cancers12092658

Ejemplares similares